TFG-ROS1 fusion
|
Sarcoma
|
TFG-ROS1 fusion
|
Sarcoma
|
crizotinib Sensitive: C3 – Early Trials
|
crizotinib Sensitive: C3 – Early Trials
|
TFG-ROS1 fusion
|
Solid Tumor
|
TFG-ROS1 fusion
|
Solid Tumor
|
entrectinib Sensitive: C3 – Early Trials
|
entrectinib Sensitive: C3 – Early Trials
|